-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Paratek Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2022.
- Paratek Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $2.23M, a 42.7% decline year-over-year.
- Paratek Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $10.3M, a 26.6% decline year-over-year.
- Paratek Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $12.3M, a 14.1% decline from 2021.
- Paratek Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $14.3M, a 39.9% increase from 2020.
- Paratek Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $10.2M, a 28.3% decline from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)